ACW vs NEU

ASX Healthcare sector comparison — updated 26 Mar 2026 — Healthcare sector

ACW

ACTINOGEN FPO [ACW]

42LOW

NEU

NEUREN FPO NZ [NEU]

43LOW

Score Breakdown

ACW NEU
Technical
62
69
Catalyst
54
50
Sentiment
50
50
Fundamental
11
52
Momentum
67
22
Risk Gate
45
36

Key Metrics

ACW Metric NEU
$128.7MMarket Cap$1.5B
2.5MAvg Volume (20d)683K
N/AShort Interest+5.9%
$0.07252-Week High$22.985
$0.01952-Week Low$8.610
-2.7%Daily Change+0.1%
$0.036Entry Price$11.945
-110.8%ROE+8.7%
-243.2%Profit Margin+47.1%

Active Signals

ACW Signals

●RSI drifting toward oversold territory — worth watching
●MACD just crossed bullish — momentum is shifting to the upside
●Stochastic is deep in oversold territory — bounce conditions forming
●Trading below both moving averages — the trend is working against this one
●Sitting near support — this level has held before and could attract buyers again
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.6 quarters)
●Piotroski F-Score weak (2/9, low-confidence approx)

NEU Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is picking up steam
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Revenue in sharp decline (-81%)
●Piotroski F-Score strong (7/9, low-confidence approx)
●EPS estimates revised upward (+10pts)

Ask Scout AI to compare ACW and NEU in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
ACW Full Analysis → NEU Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).